---
title: "How GPT-5 helped immunologist Derya Unutmaz solve a 3-year-old mystery"
slug: "gpt-5-pro-knackt-ein-drei-jahre-altes-immunologie-raetsel"
date: 2026-06-23
category: ai-provider
tags: []
language: en
sources_count: 1
featured: false
publisher: AInauten News
url: https://news.ainauten.com/en/story/gpt-5-pro-knackt-ein-drei-jahre-altes-immunologie-raetsel
---

# How GPT-5 helped immunologist Derya Unutmaz solve a 3-year-old mystery

**Published**: 2026-06-23 | **Category**: ai-provider | **Sources**: 1

---

## TL;DR

- Immunologist Derya Unutmaz had a T-cell puzzle open since 2022: low glucose and deoxyglucose were expected to behave similarly, but the lab results diverged.

---

## Summary

- Immunologist Derya Unutmaz had a T-cell puzzle open since 2022: low glucose and deoxyglucose were expected to behave similarly, but the lab results diverged.
- GPT-5 Pro suggested that deoxyglucose disrupted IL-2 production. With that brake weakened, many more T cells could specialize into inflammatory Th17 cells.
- Unutmaz also tested GPT-5 Pro on an unpublished CD8+ experiment against lymphoma cells. The model correctly predicted the stronger cancer-cell killing effect.
- OpenAI frames this as AI becoming a research collaborator. It is clearly a PR-heavy case study, but it includes enough mechanism to be more than a vague model demo.

---

## Why it matters

Immunologist Derya Unutmaz had a T-cell puzzle open since 2022: low glucose and deoxyglucose were expected to behave similarly, but the lab results diverged.

---

## Key Points

- Immunologist Derya Unutmaz had a T-cell puzzle open since 2022: low glucose and deoxyglucose were expected to behave similarly, but the lab results diverged.
- GPT-5 Pro suggested that deoxyglucose disrupted IL-2 production. With that brake weakened, many more T cells could specialize into inflammatory Th17 cells.
- Unutmaz also tested GPT-5 Pro on an unpublished CD8+ experiment against lymphoma cells. The model correctly predicted the stronger cancer-cell killing effect.
- OpenAI frames this as AI becoming a research collaborator. It is clearly a PR-heavy case study, but it includes enough mechanism to be more than a vague model demo.

---

## Nauti's Take

This is one of the better GPT-5 examples because it does not stop at magical framing. GPT-5 Pro does not replace the lab or an immunology background; it shifts where humans get unstuck, from noticing a data pattern to forming a plausible mechanism. That is where AI can become scientifically useful. The PR packaging is predictable, but the core is strong: models matter when they point researchers toward testable next experiments.

---


## FAQ

**Q:** What is How GPT-5 helped immunologist Derya Unutmaz solve a 3-year-old mystery about?

**A:** - Immunologist Derya Unutmaz had a T-cell puzzle open since 2022: low glucose and deoxyglucose were expected to behave similarly, but the lab results diverged.

**Q:** Why does it matter?

**A:** Immunologist Derya Unutmaz had a T-cell puzzle open since 2022: low glucose and deoxyglucose were expected to behave similarly, but the lab results diverged.

**Q:** What are the key takeaways?

**A:** Immunologist Derya Unutmaz had a T-cell puzzle open since 2022: low glucose and deoxyglucose were expected to behave similarly, but the lab results diverged.. GPT-5 Pro suggested that deoxyglucose disrupted IL-2 production. With that brake weakened, many more T cells could specialize into inflammatory Th17 cells.. Unutmaz also tested GPT-5 Pro on an unpublished CD8+ experiment against lymphoma cells. The model correctly predicted the stronger cancer-cell killing effect.

---

## Related Topics

- —

---

## Sources

- [How GPT-5 helped immunologist Derya Unutmaz solve a 3-year-old mystery](https://openai.com/index/gpt-5-immunology-mystery) - OpenAI News

---

## About This Article

This article is a synthesis of 1 sources, curated and summarized by AInauten News. We aggregate AI news from trusted sources and provide bilingual (German/English) coverage.

**Publisher**: [AInauten](https://www.ainauten.com) | **Site**: [news.ainauten.com](https://news.ainauten.com)

---

*Last Updated: 2026-06-26*